Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
IMRX compared with AGMB: revenue, margins and what each company keeps, and the suppliers and customers both name
IMRX
Immuneering Corp
Change
Mkt cap
Revenue
Revenue
AGMB
Agomab Therapeutics NV
Change
Mkt cap
Revenue
Revenue
vs
Compare
IMRX
Immuneering Corp
vs
AGMB
Agomab Therapeutics NV
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
IMRX
Immuneering Corp
Change
3.50
▼
−6.68%
Mkt cap
$242.3M
AGMB
Agomab Therapeutics NV
Change
6.68
▼
−10.81%
Regular session
Nov 2 '26
Mkt cap
$255.9M
vs
Compare
Regular session
Nov 2 '26
IMRX
Immuneering Corp
vs
AGMB
Agomab Therapeutics NV
3.50
▼
−6.68%
Price
6.68
▼
−10.81%
$242.3M
Mkt cap
$255.9M
Change
Change
IMRX
3.50
▼
−6.68%
vs
AGMB
6.68
▼
−10.81%
Regular session
Nov 2 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
IMRX: latest quarter not drawable. AGMB: latest quarter not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
IMRX, solid
AGMB, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only IMRX
4
LLY
Eli Lilly
supplier
REGN
Regeneron Pharmaceuticals
supplier
—
BioArkive
unlisted
supplier
—
Aventis
unlisted
customer
Shared
0
No disclosed counterparties: AGMB.
Only AGMB
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR